Pilot study to test the efficacy and safety of activated recombinant factor VII (NovoSeven) in the treatment of refractory hemorrhagic cystitis following high-dose chemotherapy [3]

A. A. Ashrani; D. A. Gabriel; J. L. Gajewski; D. R. Jacobs; D. J. Weisdorf; N. S. Key

doi:10.1038/sj.bmt.1705535

Pilot study to test the efficacy and safety of activated recombinant factor VII (NovoSeven) in the treatment of refractory hemorrhagic cystitis following high-dose chemotherapy [3]

A. A. Ashrani, D. A. Gabriel, J. L. Gajewski, D. R. Jacobs, D. J. Weisdorf, N. S. Key

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	825-828
Number of pages	4
Journal	Bone marrow transplantation
Volume	38
Issue number	12
DOIs	https://doi.org/10.1038/sj.bmt.1705535
State	Published - Dec 2006
Externally published	Yes

ASJC Scopus subject areas

Hematology
Transplantation

Access to Document

10.1038/sj.bmt.1705535

Cite this

Pilot study to test the efficacy and safety of activated recombinant factor VII (NovoSeven) in the treatment of refractory hemorrhagic cystitis following high-dose chemotherapy [3]. / Ashrani, A. A.; Gabriel, D. A.; Gajewski, J. L. et al.
In: Bone marrow transplantation, Vol. 38, No. 12, 12.2006, p. 825-828.

Research output: Contribution to journal › Letter › peer-review

@article{3af729c9d5744761aa98d35b654e5b83,

title = "Pilot study to test the efficacy and safety of activated recombinant factor VII (NovoSeven) in the treatment of refractory hemorrhagic cystitis following high-dose chemotherapy [3]",

author = "Ashrani, {A. A.} and Gabriel, {D. A.} and Gajewski, {J. L.} and Jacobs, {D. R.} and Weisdorf, {D. J.} and Key, {N. S.}",

year = "2006",

month = dec,

doi = "10.1038/sj.bmt.1705535",

language = "English (US)",

volume = "38",

pages = "825--828",

journal = "Bone marrow transplantation",

issn = "0268-3369",

publisher = "Nature Publishing Group",

number = "12",

}

TY - JOUR

T1 - Pilot study to test the efficacy and safety of activated recombinant factor VII (NovoSeven) in the treatment of refractory hemorrhagic cystitis following high-dose chemotherapy [3]

AU - Ashrani, A. A.

AU - Gabriel, D. A.

AU - Gajewski, J. L.

AU - Jacobs, D. R.

AU - Weisdorf, D. J.

AU - Key, N. S.

PY - 2006/12

Y1 - 2006/12

UR - http://www.scopus.com/inward/record.url?scp=33751550915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751550915&partnerID=8YFLogxK

U2 - 10.1038/sj.bmt.1705535

DO - 10.1038/sj.bmt.1705535

M3 - Letter

C2 - 17133240

AN - SCOPUS:33751550915

SN - 0268-3369

VL - 38

SP - 825

EP - 828

JO - Bone marrow transplantation

JF - Bone marrow transplantation

IS - 12

ER -

Pilot study to test the efficacy and safety of activated recombinant factor VII (NovoSeven) in the treatment of refractory hemorrhagic cystitis following high-dose chemotherapy [3]

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this